Page 12 - AN-2-2

Advanced Neurology Venous stenting, intracranial hypertension

the combination of which can, in rare cases, lead to a de References
novo formation of dural arteriovenous fistula .
[40]
1. Bayot ML, Reddy V, Zabel MK, 2022, Neuroanatomy, dural
Restenosis is a common cause of failure in stenting venous sinuses. In: StatPearls. Treasure Island, FL: StatPearls
and can occur in an existing stent or in an adjacent stent. Publishing.
However, the mechanism of which it occurs is unknown . 2. Hufnagle JJ, Tadi P, 2022, Neuroanatomy, brain veins. In:
[8]
The long-term outcomes of CVSS are promising [48,49] . StatPearls. Treasure Island, FL: StatPearls Publishing.
In a single-center real-world cohort study by Xu et al., 3. Puffer RC, Mustafa W, Lanzino G, 2013, Venous sinus
98.3% of patients showed improvements in papilledema stenting for idiopathic intracranial hypertension: A review
and the headaches in 96% of patients (n = 62) resolved of the literature. J Neurointerv Surg, 5: 483–486.
after 12~126 months (median 62 months). However, https://doi.org/10.1136/neurintsurg-2012-010468
adverse effects such as optic disc atrophy and tent- 4. Daggubati LC, Liu KC, 2019, Intracranial venous sinus
interior thrombosis were reported in 8% of patients after stenting: A review of idiopathic intracranial hypertension
[48]
6.3 months . and expanding indications. Cureus, 11: e4008.
8. Conclusion https://doi.org/10.7759/cureus.4008
Cerebral venous stent placement remains a viable option 5. Kilgore KP, Lee MS, Leavitt JA, et al., 2017, Re-evaluating
for patients experiencing symptoms of IIH, including the incidence of idiopathic intracranial hypertension in an
headaches, vision loss, and pulsatile tinnitus. The clinical era of increasing obesity. Ophthalmology, 124: 697–700.
use of CVSS in the treatment of IIH and associated https://doi.org/10.1016/j.ophtha.2017.01.006
symptoms is promising; however, vigorous research is 6. Gaier ED, Heidary G, 2019, Pediatric idiopathic intracranial
required to further evaluate to efficacy of this procedure. hypertension. Semin Neurol, 39: 704–710.
Developments such as the Cobra and SAVeS techniques https://doi.org/10.1055/s-0039-1698743
present promising improvements to CVSS.
7. Sheldon CA, Paley GL, Beres SJ, et al., 2017, Pediatric
Acknowledgments pseudotumor cerebri syndrome: Diagnosis, classification,
and underlying pathophysiology. Semin Pediatr Neurol,
None. 24: 110.
Funding https://doi.org/10.1016/J.SPEN.2017.04.002

None. 8. Gurney SP, Ramalingam S, Thomas A, et al., 2020,
Exploring the current management idiopathic intracranial
Conflict of interest hypertension, and understanding the role of dural venous
sinus stenting. Eye Brain, 12: 1–13.
The authors declare that they have no conflict of interest.
https://doi.org/10.2147/EB.S193027
Author contributions 9. Farb RI, Vanek I, Scott JN, et al., 2003, Idiopathic
intracranial hypertension: The prevalence and morphology
Conceptualization: Persis Desai, Brandon Lucke-Wold of sinovenous stenosis. Neurology, 60: 1418–1424.
Writing – original draft: Persis Desai, Oluwaferanmi Dada,
Jamie Warner, Kevin Pierre https://doi.org/10.1212/01.wnl.0000066683.34093.e2
Writing – review & editing: Persis Desai, Oluwaferanmi 10. Ball AK, Clarke CE, 2006, Idiopathic intracranial
Dada, Jamie Warner, Kevin Pierre, Brandon Lucke- hypertension. Lancet Neurol, 5: 433–442.
Wold https://doi.org/10.1016/S1474-4422(06)70442-2

Ethics approval and consent to participate 11. Thurtell MJ, 2019, Idiopathic intracranial hypertension.
Continuum (Minneap Minn), 25: 1289–1309.
Not applicable.
https://doi.org/10.1212/CON.0000000000000770
Consent for publication 12. Shaw GY, Million SK, 2012, Benign intracranial
Not applicable. hypertension: A diagnostic dilemma. Case Rep Otolaryngol,
2012: 814696.
Availability of data https://doi.org/10.1155/2012/814696
Not applicable. 13. Friedman DI, Liu GT, Digre KB, 2013, Revised diagnostic

Volume 2 Issue 2 (2023) 6 https://doi.org/10.36922/an.284